NT157 is a small-molecule tyrphostin targeting human IRSes.
1. Krueckl SL et al. Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model. Cancer Res. 2004;64:8620.
2. Gleave M, Cox M, Wang YZ: Cell biology of prostate cancer and molecular targets. In Drug Management of Prostate Cancer. (Figg, Chau, Small, Eric, Eds.) Humana Press, Springer New York Dordrecht Heidelberg London, 2010.
3. Reuveni H et al. Therapeutic Destruction of Insulin Receptor Substrates for Cancer Treatment. Cancer Res 2013;73:4383.